News Coverage for
Technologies Scan Corp. (OTCQB: TENP) -
August 26, 2013 |
- Last Trade: $
- Change:
- Open: $
- High: $
- Low: $
- Volume:
Company Snapshot |
Technologies Scan Corp.
331 Labelle
St-Jerome, QC J7Z 5L2
Canada
www.techno-scan.com
Directors:
Ghislaine St-Hilaire, President
Gilbert Pomerleau CFO, Treasurer
Tel: 450-504-6923
Email: info@techno-scan.com
Ticker Symbol: TENP
Exchange: OTCQB
Shares Outstanding: 117,650,000
Float: APX 37,150,000 +/-
52 Week Low: $0.01
52 Week High: $0.243
|
TENP Mobi Site |
Never miss news alerts from
TENP -
Text PRESS to 545454 for
Free News Alerts |
Technologies –Scan Corp announces upcoming USA
launch for its Proteina21 weight loss product
line
Montreal,
Canada, August 26, 2013, Technologies –Scan Corp
( OTCQB: TENP ) is pleased to announce the
upcoming USA launch of its Proteina21 product
line scheduled for November 1 2013 thus entering
the 66 billion dollar USA weight loss market.
The company has ordered thru Social Geek Media,
it’s licensor of the Proteina21 license for the
USA, the necessary product inventory for its
initial USA launch.
Get
News
Alerts &
Stock Updates for Technologies Scan
delivered directly to your Mobile Phone. Text
PRESS
to 545454
(News alerts are free; however standard
message & data rates may apply. Check with your
carrier for more details.)
lProteina21
is a product line of food supplements and
readymade meals high in protein and low in
carbohydrates designed to help people lose
weight. The Proteina21 product line will consist
of several different weight loss products. The
products are shipped overnight and are available
thru internet sales on their website
www.proteina21.com
About Technologies-Scan Corp (OTCQB: TENP)
Technologies-Scan Corp is database management
company specializing in the development of
several internet base software applications for
the health and consumer wellbeing markets. The
company signed an exclusive USA marketing and
distribution license for the Proteina21 weight
loss products line.
"Safe Harbor"
Statement under the Private Securities
Litigation Reform Act of 1995: This release
includes forward-looking statements intended to
qualify for the safe harbor from liability
established by the Private Securities Litigation
Reform Act of 1995. All statements which address
actual results could differ materially from
those expressed or implied in forward-looking
statements. These statements are made on the
basis of management's views and assumptions. As
a result, there can be no assurance that
management's expectations will necessarily come
to pass. These forward-looking statements
generally can be identified by phrases such as
management "believes," "expects," "anticipates,"
"foresees," "forecasts," "estimates" or other
words or phrases of similar import. Similarly,
statements in this release that describe the
Company's business strategy, outlook,
objectives, plans, intentions or goals also are
forward-looking statements. All such
forward-looking statements are subject to
certain risks and uncertainties that could cause
actual results to differ materially from those
in forward-looking statements. Management
cautions that the ability to attract clients and
generate business may be affected by a decline
in the Company's financial ratings, the
competitive environment, the Company's ability
to raise sufficient capital to meet the
collateral requirements associated with its
current business and to fund the Company's
continuing operations and changes in market
conditions.
Technologies-Scan Corp
Investor relations
1-855-492-5245
About Technologies Scan Corp. (OTCQB: TENP) |
Discover a fast growing
company
We are a development stage company whose plan of
operation is selling and distributing health
products, including a health database
system. We have developed an exhaustive database
and software for natural health products. We
believe our Medicus21software is a unique
information provider of natural health products
to be used through a mobile application and
barcode reader. It enables the user to scan any
natural health product’s bar code, through the
help of their smart phone, and instantly obtain
all nutritional information, use, benefits and a
plethora of information on the product.
Our Joint Venture with SGM includes the design,
technologies, how to, development, production
and sale of nutritional, protein and dietary
supplements online. All Proteina21 products have
common features, including:
1) A flavor, taste and format tailored to market
needs;
2) Quick and easy preparation;
3) Scientific formulation;
4) Rigorous manufacturing standards.
Proteina21
Proteïna21 specializes in the development and
marketing of protein-based food products and
supplements.
The company has enjoyed rapid growth over the
last year, steadily making a name for itself
around the Canada.
We
do not limit ourselves to purely commercial
objectives: our primary goal is to help people
lose weight and keep it off, all the while
respecting nutrition and medical ethics.
A dynamic team
In order to provide our customers with the very
best of weight loss products, we have gathered a
team of young and dynamic specialists.
Our research and development department is
working hard to deliver quality products that
meet the needs of a modern clientele. It is
supported in this task by the raw material
purchasing department.
We at Proteïna21 care about our customers’
satisfaction - this is why our customer service
is always there to assist you and answer your
questions. "Easy and clear communication is
essential to mutual understanding" - this policy
allows us to provide our customers with the
quality of service they deserve.
A dedicated production team
Our production team is at the heart of the
company’s operations – the strictest rules of
hygiene are respected to ensure the high quality
of the final product. Additionally, our quality
control department guarantees the safety of our
products, from reception of raw materials to
shipping in compliance with the requirements of
the Canadian Food Inspection Agency.
Our management staff is composed of experts with
many years of experience - whether they’re
working in technical management, public
relations, general management, accounting, or
technical writing.
Research and Development
In order to improve existing products and create
new ones, Proteïna21 focuses on research and
development. This constant investment allows the
company to maintain a leading position in its
field and to enjoy record-breaking achievements
in both quality and productiveness.
Creating great-tasting food products (and
especially dietary products) requires many
months of hard work; each formulation is
carefully researched and improved to make the
product a leader in its category in terms of
flavor and quality.
Once a product has been produced, it undergoes a
battery of tests (quality control, nutritional
analysis, microbiological and organoleptic
tests). All products are manufactured in strict
compliance with the prescribed standards and
norms of the industry.
Proteïna21’s leading managers are committed to
creating mouthwatering protein and dietary
products and supplements that will spark the
consumers’ interest. Over the next few years,
the company plans on expanding its product line
even further in order to offer even more flavors
and weight-loss delights to its customers.
Recent Technologies Scan Corp. (OTCQB: TENP) |
Technologies-Scan Corp Launches Updated
Website to Reflect New Distribution and License
Agreement With Proteina21 Weight Loss Product
LineMONTREAL, QUEBEC, Jun
05, 2013 (Marketwired via COMTEX) --
Technologies-Scan Corp (OTCQB: TENP) updates its
current website www.techno-scan.com to reflect
the new sales and distribution agreement with
Proteina21 weight loss product line. "The new
website is designed to better reflect what we
are doing with Proteina21" says CEO Patrick
Aube." Having myself a strong background in
internet sales and technology, updating the
website was a priority for me when we signed the
license agreement for the weight loss product
line. It is the corner stone of our business
model and thus special attention must be put on
this aspect of the business" added Aube. The
website will reflect the new direction the
company is going with the online Proteina21
weight loss products.
Technologies-Scan Corp owns an exclusive
distribution, sales and marketing license for
Proteina21 weight loss products for the US
market and options on Canadian and European
markets.
Proteina21 is a product line of food supplements
and readymade meals high in protein and low in
carbohydrates designed to help people lose
weight. The products are shipped overnight and
are available thru internet sales on their
website at
www.proteina21.com
Technologies-Scan Corp Announces the
Nomination of Patrick Aube as New CEO
MONTREAL, QUEBEC, May 29, 2013 (Marketwired
via COMTEX) -- Technologies-Scan Corp (OTCQB:
TENP) is proud to announce the nomination of
Patrick Aube as new CEO. "This move was part of
the plan when we signed the license agreement,"
says Ghislaine St-Hilaire, the now former CEO.
"Patrick Aube is a serial entrepreneur with over
18 years experience in computer technologies and
Internet sales, his expertise will greatly
benefit the company and shareholders, Patrick is
a recognized Internet marketing expert and
author of a bestselling book sold in 40
countries on all you need to know to generate
income on the Internet and was nominated as
Entrepreneur of the Year in the prestigious
Ernst & Young 2010 contest," added St-Hilaire.
Aube created Social Media Geek Inc and operates
the popular website www.chezmaya.com, one of the
largest French-speaking websites in the world,
with over one million unique visitors every
month. Social Media Geek also specializes in
database technology and media social networks.
Technologies-Scan Corp owns an exclusive
distribution, sales and marketing license for
Proteina21 weight loss products for the US
market, and options for Canadian and European
markets.
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM) is a third party
publishing provider which disseminates
electronic information through multiple online
media channels. FNMG's intended purposes are to
deliver market updates and news alerts issued
from private and publicly trading companies as
well as providing coverage and increased
awareness for companies that issue press to the
public via online newswires. FNMG and its
affiliated companies are a news dissemination
and financial marketing solutions provider and
are NOT a registered
broker/dealer/analyst/adviser, holds no
investment licenses and may NOT sell, offer to
sell or offer to buy any security. FNMG's market
updates, news alerts and corporate profiles are
NOT a solicitation or recommendation to buy,
sell or hold securities. An offer to buy or sell
can be made only with accompanying disclosure
documents from the company offering or selling
securities and only in the states and provinces
for which they are approved. The material in
this release is intended to be strictly
informational and is NEVER to be construed or
interpreted as research material. All readers
are strongly urged to perform research and due
diligence on their own and consult a licensed
financial professional before considering any
level of investing in stocks. The companies that
are discussed in this release may or may not
have approved the statements made in this
release. Information in this release is derived
from a variety of sources that may or may not
include the referenced company's publicly
disseminated information. The accuracy or
completeness of the information is not warranted
and is only as reliable as the sources from
which it was obtained. While this information is
believed to be reliable, such reliability cannot
be guaranteed. FNMG disclaims any and all
liability as to the completeness or accuracy of
the information contained and any omissions of
material fact in this release. This release may
contain technical inaccuracies or typographical
errors. It is strongly recommended that any
purchase or sale decision be discussed with a
financial adviser, or a broker-dealer, or a
member of any financial regulatory bodies.
Investment in the securities of the companies
discussed in this release is highly speculative
and carries a high degree of risk. FNMG is not
liable for any investment decisions by its
readers or subscribers. Investors are cautioned
that they may lose all or a portion of their
investment when investing in stocks.
This release is not without bias, and is
considered a conflict of interest if
compensation has been received by FNMG for its
dissemination. To comply with Section 17(b) of
the Securities Act of 1933, FNMG shall always
disclose any compensation it has received, or
expects to receive in the future, for the
dissemination of the information found herein on
behalf of one or more of the companies mentioned
in this release. For services performed FNMG has
been compensated one thousand five hundred dollars for
coverage on this TENP news release by a non-affiliated third party. FNMG HOLDS
NO SHARES OF Technologies Scan Corp. (OTCQB:
TENP)
This release contains "forward-looking
statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and
Section 21E the Securities Exchange Act of 1934,
as amended and such forward-looking statements
are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe
future expectations, plans, results, or
strategies and are generally preceded by words
such as "may", "future", "plan" or "planned",
"will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are
cautioned that such statements are subject to a
multitude of risks and uncertainties that could
cause future circumstances, events, or results
to differ materially from those projected in the
forward-looking statements, including the risks
that actual results may differ materially from
those projected in the forward-looking
statements as a result of various factors, and
other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings
made by such company with the Securities and
Exchange Commission. You should consider these
factors in evaluating the forward-looking
statements included herein, and not place undue
reliance on such statements. The forward-looking
statements in this release are made as of the
date hereof and FNMG undertakes no obligation to
update such statements.
|